Publications by authors named "Doug Arbetter"

Claim this Profile
L
Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY).
Doug Arbetter, Vancheswaran Gopalakrishnan, Anastasia A Aksyuk, Bahar Ahani, Yue Chang

Clin Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years.
Stephanie Korn, Arnaud Bourdin, Geoffrey Chupp, Borja G Cosio, Doug Arbetter

J Allergy Clin Immunol Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis